• Cervical cancer: psychologic distress tied to higher mortality risk

    Distress within 1 year before or after cancer diagnosis increases mortality.

  • Cervical cancer: paclitaxel-carboplatin-bevacizumab shows efficacy in phase 2

    Objective response rate was 88% in advanced/recurrent disease.

  • Cervical cancer: doubled risk for death with minimally invasive surgery

    Recurrence risk also doubled vs open radical hysterectomy.

  • HPV vaccine could prevent thousands of cancers over the next few decades
    HPV vaccine could prevent thousands of cancers over the next few decades

    Estimates based on a modelling by the University of Warwick.

  • Bevacizumab biosimilar gets FDA nod for 5 cancer types

    Bevacizumab-bvzr could offer a cheaper alternative to the reference product.

  • HPV vaccination programmes have substantial impact in reducing HPV infections and precancerous cervical lesions
    HPV vaccination programmes have substantial impact in reducing HPV infections and precancerous cervical lesions

    The meta-analysis shows greater and faster impact and herd effects in countries with both multi-cohort and high vaccination coverage.

  • NHS urges women to get cervical cancer screening regardless of their sexual orientation
    NHS urges women to get cervical cancer screening regardless of their sexual orientation

    There is a misbelief that lesbian, gay and bisexual women are not at risk of cervical cancer.

  • European organizations strongly in favor of gender-neutral HPV vaccination

    HPV vaccination, testing best for preventing cervical cancer.

  • Cervical cancer: no survival benefit for ACT after concurrent chemoradiation

    Findings from ACTLACC trial.

  • Cervical cancer: chemoradiation with doublet tops monotherapy in meta-analysis

    Platinum-based doublet therapy was less tolerable.

  • Cervical cancer: HDR brachytherapy effective with less toxicity

    Similar local disease control, cancer-specific survival vs LDR brachytherapy.

  • The impact of the HSCA on cervical cancer screening rates

    Exploring the impacts of the 2012 Health and Social Care Act reforms on clinical activity in the English NHS.

  • Northern Ireland's health department makes two major health protection declarations
    Northern Ireland's health department makes two major health protection declarations

    Announcements pertaining to HPV vaccination and bowel screening.

  • Cervical cancer: cetuximab fails phase 2 in advanced/recurrent disease

    PIK3CA mutation status predicted resistance to cetuximab.

  • Therapeutic vaccine targets HPV, clears cervical cancer precursors

    Phase 2 trial shows efficacy regardless of high-risk HPV type.

  • Cervical cancer: the study behind FDA approval of pembrolizumab

    Data from the phase 2 pembrolizumab KEYNOTE-158 basket study.

  • AACR 2019—​​​​​​​HPV vaccination rates low in adults at high risk for HIV

    HIV coinfection increases HPV-related cancer risk.

  • Load more